Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the methenamine hippurate tablets market right now?

There has been a substantial surge in the market size of methenamine hippurate tablets in recent years. The forecast shows an increase from $9.52 billion in 2024 to $10.21 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.2%. This progression in the historic phase is influenced by several factors such as conventional UTI treatment, worries over antibiotic resistance, clinical approval, the prescribing habits of physicians, and patients opting for non-antibiotic remedies.

How fast Is the methenamine hippurate tablets market expected to grow, and what’s its future value?

The market for methenamine hippurate tablets is predicted to observe a robust increase in the coming years, growing to $13.78 billion in 2029 with a compound annual growth rate (CAGR) of 7.8%. Factors that will contribute to this growth during the projected period include the increasing UTI cases, escalating issues with antibiotic resistance, improvements in UTI management, emphasis on preventive treatments by healthcare professionals, as well as clinical studies and research. There are significant trends projected for the forecast period such as intensified UTI incidences, escalating antibiotic resistance, the inclination towards non-antibiotic remedies, emphasis on preventive health care, along with research and development.

Get your methenamine hippurate tablets market report here!

https://www.thebusinessresearchcompany.com/report/methenamine-hippurate-tablets-global-market-report

What are the leading drivers of growth in the methenamine hippurate tablets market?

The expected increase in the population of elderly individuals, typically aged 60 and above, is predicted to stimulate the growth of the methenamine hippurate tablets market. This geriatric population is more susceptible to urinary tract conditions, including infections, due to various reasons such as decreased urine flow, enlarged prostate, or kidney stones. Therefore, methenamine hippurate tablets are essential for their treatment. As per the World Health Organization, a specialized agency of the United Nations based in Switzerland and responsible for international public health, it is projected that by 2030 one out of every six people globally will be 60 or above. In 2022, there were approximately 1.4 billion people across the globe who were over 60. This demographic is estimated to double by 2050, reaching 2.1 billion. Additionally, the population of people ages 80 and older will triple, amounting to 426 million. Consequently, the growth of the methenamine hippurate tablets market is being fueled by the steady rise in the elderly population.

What are the key segments defining the methenamine hippurate tablets market?

The methenamine hippurate tablets market covered in this report is segmented –

1) By Type: 20 Tablets Or Bottle, 6 Tablets Or Bottle

2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

3) By Application: Uncomplicated UTIs, Healthcare-associated UTIs

4) By End User: Hospitals, Homecare, Specialty Clinics, Others End Users

Subsegments:

1) By 20 Tablets per Bottle: Standard Packaging, Bulk Packaging Options

2) By 6 Tablets per Bottle: Standard Packaging, Sample Or Trial Packaging

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9412&type=smp

Who are the key players steering the development of the methenamine hippurate tablets market?

Major companies operating in the methenamine hippurate tablets market include Alvogen Lux Holdings S.ÀR.L., Micro Labs Inc., Aurobindo Pharma, Amneal Pharmaceuticals Inc., Viatris Inc., McKesson Corporation, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Zydus Pharmaceuticals Ltd., Lupin Ltd., Alkem Laboratories Ltd., Ipca Laboratories Ltd., Granules India Ltd., Teva Pharmaceutical Industries Ltd., Apotex Pharmachem Inc., Sandoz International GmbH

What emerging trends are influencing the growth of the methenamine hippurate tablets market?

The primary trend gaining traction in the methenamine hippurate tablets marketplace is product innovation. Leading firms in this sector are introducing unique products to establish their market dominance. For example, EQL Pharma, a Europe-based pharmaceutical firm focusing on the production and sale of affordable generic and niche generics to retailers and hospitals, announced in May 2023 that it has granted Laboratoires Majorelle the out-license for Memprex (methenamine hippurate) to increase its reach in the French market and offer a non-antibiotic alternative for UTI prevention. Laboratoires Majorelle, a significant player in women’s health in France, is set to market and distribute Memprex, providing a non-antibiotic solution for UTI prevention.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9412

Which regions are most influential in expanding the methenamine hippurate tablets market?

North America was the largest region in the methenamine hippurate tablets market in 2024. The regions covered in the methenamine hippurate tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Medical Foods Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/medical-foods-global-market-report

Contraceptives Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Oral Contraceptive Pills Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: